Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in pharmaceutical

Fujifilm Seeks Approval For Avigan As COVID-19 Treatment In Japan

Fujifilm in July signed a deal with India's Dr Reddy's Laboratories and Dubai-based Global Response Aid to sell Avigan for COVID-19 globally, excluding in China, Japan and Russia.

Read More

Glenmark Pharma Gets USFDA Nod For Generic Drug

The company's US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of PF Prism CV's Rapamune tablets

Read More

China's Sinopharm Offers Experimental COVID-19 Vaccines To Students

China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group and U.S.-listed Sinovac Biotech.

Read More

J&J Pauses COVID-19 Vaccine Trials Due To Unexplained Illness In Participant

J&J's move follows a similar one by AstraZeneca Plc. In September, AstraZeneca paused late-stage trials of its experimental coronavirus vaccine, developed with the University of Oxford, due to an unexplained illness in a UK study participant.

Read More

Johnson & Johnson pauses vaccine trial after volunteer falls ill

Johnson & Johnson pauses vaccine trial after volunteer falls ill

Read More

AstraZeneca Still Waiting For FDA Go-Ahead To Resume U.S. Trial

A document posted online by Oxford university last week stated the illness in a British participant that triggered the pause on Sept. 6 may not have been associated with the vaccine.

Read More

BioNTech CEO Expects Vaccine Can Be Fridge-Stored For Two Weeks

A good vaccine should have an efficacy of at least 70% to 75% for it to quell the pandemic and that was also the yardstick that BioNTech had set itself.

Read More

Astrazeneca To Begin Phase 1/2 Clinical Trials Of Coronavirus Vaccine In Japan

Trials of the vaccine, known as AZD1222, will be conducted at multiple facilities in Japan, targeting 250 subjects, the company said in a release.

Read More

Sanofi Snags Another US Biotech Asset With $3.7 Billion Deal For Principia Biopharma

Sanofi shares edged up 0.6% in early session trading, bucking a slight fall in France's CAC-40 index, as analysts were positive on the deal.

Read More

Special Relocation Incentive Will Attract Global Firms To shift From China To Gujarat: Gujarat CM Vijay Rupani

The Government of Gujarat has launched New Industrial Policy 2020, initiating Relocation Incentives. Gujarat does attract FDI from many counties for the ease of doing business and conducive investor friendly policy but that that has not happened for the global investors who are planning to shift from China in big way. On such policy issues, Gujarat Chief Minister Vijay Rupani speaks with BW Businessworld's Manish Kumar Jha.

Read More

Japan Says In Deal To Purchase Astrazeneca's COVID-10 Vaccine

The agreement comes after Japan announced a deal last week to buy 120 million doses of a COVID-19 vaccine candidate developed by Pfizer Inc and BioNTech SE.

Read More

U.S. FDA Approves Glaxosmithkline's Blood Cancer Drug

Multiple myeloma is the second most common form of blood cancer in the U.S. and is generally considered treatable, but not curable.

Read More

China's Factories Accelerate Recovery In July As Demand Perks Up

Profits at China’s large industrial firms also rose at the fastest pace in over a year that month on easing costs and improving demand.

Read More

Gilead Raises Sales Outlook To Include COVID-19 Treatment Remdesivir

Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv.

Read More

Roche Bid To Retool Arthritis Drug For COVID-19 Fails

Pharmaceutical companies have been racing to develop treatments against the COVID-19 pandemic that has claimed nearly 660,000 lives and crippled economies.

Read More